760 related articles for article (PubMed ID: 3756921)
1. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
2. Ligand-induced phosphorylation of a murine tumor surface protein (TSP-180) associated with metastatic phenotype.
Sacchi A; Falcioni R; Piaggio G; Gianfelice MA; Perrotti N; Kennel SJ
Cancer Res; 1989 May; 49(10):2615-20. PubMed ID: 2713845
[TBL] [Abstract][Full Text] [Related]
3. MHC antigens expressed on 3LL metastatic variants: correlation with the expression of a TSP-180 protein.
Sacchi A; Falcioni R; Tibursi G; Apollonj Ghetti C
Adv Exp Med Biol; 1988; 233():141-50. PubMed ID: 3223380
[TBL] [Abstract][Full Text] [Related]
4. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
5. Metastatic phenotype: growth factor dependence and integrin expression.
Perrotti D; Cimino L; Falcioni R; Tibursi G; Gentileschi MP; Sacchi A
Anticancer Res; 1990; 10(6):1587-97. PubMed ID: 2285230
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells.
Sacchi A; Piaggio G; Rizzo MA; Falcioni R; Kennel SJ
Clin Exp Metastasis; 1989; 7(1):41-54. PubMed ID: 2783240
[TBL] [Abstract][Full Text] [Related]
7. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
LeGrue SJ; Hearn DR
Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
[TBL] [Abstract][Full Text] [Related]
8. High levels of Met-72 antigen expression: correlation with metastatic activity of B16 melanoma tumor cell variants.
Kimura AK; Xiang JH
J Natl Cancer Inst; 1986 Jun; 76(6):1247-54. PubMed ID: 3486997
[TBL] [Abstract][Full Text] [Related]
9. Tumor antigen on benign adenomas and on murine lung carcinomas quantitated by a two-site monoclonal antibody assay.
Kennel SJ; Foote LJ; Flynn KM
Cancer Res; 1986 Feb; 46(2):707-12. PubMed ID: 3940637
[TBL] [Abstract][Full Text] [Related]
10. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
Herd ZL
Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203
[TBL] [Abstract][Full Text] [Related]
11. Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan.
Kure S; Yoshie O; Aso H
Jpn J Cancer Res; 1987 Nov; 78(11):1238-45. PubMed ID: 2961717
[TBL] [Abstract][Full Text] [Related]
12. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
Yu HR; Schultz RM
Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350
[TBL] [Abstract][Full Text] [Related]
13. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
Parratto NP; Odebralski JM; Kimura AK
Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512
[TBL] [Abstract][Full Text] [Related]
14. Treatment with monoclonal antibody to a Lewis lung carcinoma-associated antigen: different effects on primary tumor and its metastases.
Sacchi A; Kennel SJ; Apollonj C; Natali PG
Cancer Treat Rep; 1985 Sep; 69(9):985-91. PubMed ID: 4028039
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.
Nicolson GL; Inoue T; Van Pelt CS; Cavanaugh PG
Cancer Res; 1990 Feb; 50(3):515-20. PubMed ID: 2297694
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody to human carcinoma-associated protein complex: quantitation in normal and tumor tissue.
Falcioni R; Sacchi A; Resau J; Kennel SJ
Cancer Res; 1988 Feb; 48(4):816-21. PubMed ID: 2448027
[TBL] [Abstract][Full Text] [Related]
17. Detection of malignant melanoma with monoclonal antibodies.
Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ
Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264
[TBL] [Abstract][Full Text] [Related]
18. Identification of immunogenic B16 melanoma-associated antigens.
Johnston D; Schachne JP; Bystryn JC
J Biol Response Mod; 1987 Apr; 6(2):108-20. PubMed ID: 3585408
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic diversity of murine B16 melanoma detected by anti-B16 monoclonal antibodies.
Johnson CW; Barth RF; Adams D; Holman B; Price JE; Sautins I
Cancer Res; 1987 Feb; 47(4):1111-7. PubMed ID: 2433032
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody to Lewis lung carcinoma variant H-59 identifies a plasma membrane protein with apparent relevance to lymph node adhesion and metastasis.
Shestowsky W; Fallavollita L; Brodt P
Cancer Res; 1990 Mar; 50(6):1948-53. PubMed ID: 2407349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
